Cell and Gene Therapy Insights Volume 6 Issue 11

CELL AND GENE THERAPY INSIGHTS

Volume 6 Issue 11

Cell and Gene Therapy Insights Volume 6 Issue 11

Download PDF

Featuring

Issue Spotlight: Tools of tomorrow
Vectors focus: Purification 2020
Other articles

Tools of tomorrow

Review

Detection of extracellular analytes via nanoscale optical sensors

Detection of extracellular analytes via nanoscale optical sensors

I Acosta, A Haworth, B Francis et al.

Innovator Insight

What to expect in 2021: seven cell and gene therapy commercialization trends

What to expect in 2021: seven cell and gene therapy commercialization trends

10 December 2020

Expert Roundtable Video

Viral vector production process intensification: analytics, automation, in-line testing, and more

Viral vector production process intensification: analytics, automation, in-line testing, and more

S D’Costa, M Delahaye, M DiBiasio-White et al.

18 January 2021

Expert Roundtable

Viral vector production process intensification: analytics, automation, in-line testing and more

Viral vector production process intensification: analytics, automation, in-line testing and more

9 February 2021

Commentary

Tools for tomorrow: expression without cells

Tools for tomorrow: expression without cells

Jade Tuck, Stuart Jamieson, Philip Probert

Podcast

An innovative collaborative approach towards the development of gene therapies for rare and ultra-rare genetic disorders of the CNS

An innovative collaborative approach towards the development of gene therapies for rare and ultra-rare genetic disorders of the CNS

Leszek Lisowski, PhD, MBA, Wendy Gold

22 December 2020

Interview

An innovative collaborative approach towards the development of gene therapies for rare and ultra-rare genetic disorders of the CNS

An innovative collaborative approach towards the development of gene therapies for rare and ultra-rare genetic disorders of the CNS

23 December 2020

The engineer’s perspective: evolution in cell therapy bioprocess automation

The engineer’s perspective: evolution in cell therapy bioprocess automation

Brijender Parsad

23 December 2020

Redeploying biopharma process development and validation best practices for cell and gene therapy

Redeploying biopharma process development and validation best practices for cell and gene therapy

Suzanne Aldington

23 December 2020

Widening the reach of induced pluripotent stem cell-based therapy

Widening the reach of induced pluripotent stem cell-based therapy

16 December 2020

Purification 2020

Innovator Insight

Scalable AAV manufacturing: addressing challenges across the workflow

Scalable AAV manufacturing: addressing challenges across the workflow

18 January 2021

Podcast

Empty/full separation: gene therapy’s hidden challenge

Empty/full separation: gene therapy’s hidden challenge

22 January 2021

Interview

Empty/full separation: gene therapy’s hidden challenge

Empty/full separation: gene therapy’s hidden challenge

22 January 2021

Achieving optimal downstream bioprocessing for AAV vector

Achieving optimal downstream bioprocessing for AAV vector

23 December 2020

articles

FastFacts

Navigating cell therapy supply chain complexities during the COVID-19 pandemic

Navigating cell therapy supply chain complexities during the COVID-19 pandemic

16 December 2020

Perspective

Exosomes as therapeutics and drug delivery vehicles: global regulatory perspectives

Exosomes as therapeutics and drug delivery vehicles: global regulatory perspectives

Shaun Stapleton

17 December 2020

Interview

A year like no other: reflecting on the challenges of 2020, and looking to regain momentum for cell and gene therapy in 2021

A year like no other: reflecting on the challenges of 2020, and looking to regain momentum for cell and gene therapy in 2021

Peter Marks, MD, PhD